Rational use of antibiotics in children with diabetic ketoacidosis needs attention

Xu Wang1

  • 1Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China. sepnine@njmu.edu.cn.

Insights

Diabetic ketoacidosis (DKA) in children can cause acute kidney injury (AKI). Some children experience delayed kidney function recovery, potentially due to drug-disease interactions, necessitating careful monitoring.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Critical Care Medicine

Background:

  • Diabetic ketoacidosis (DKA) is a serious complication of diabetes in children.
  • Acute kidney injury (AKI) is a recognized, though often under-recognized, complication of DKA.
  • The long-term renal outcomes for pediatric DKA patients, especially those with AKI, require further investigation.

Purpose of the Study:

  • To investigate the incidence and outcomes of AKI in pediatric patients with DKA.
  • To identify potential risk factors and complications associated with AKI in this population.
  • To highlight the importance of monitoring kidney function in children following DKA.

Main Methods:

  • Retrospective chart review of pediatric patients admitted with DKA.
  • Analysis of kidney function parameters at admission, during hospitalization, and post-discharge.
  • Identification of AKI cases based on established diagnostic criteria.

Main Results:

  • Eight out of 45 pediatric DKA patients (17.8%) presented with AKI on admission.
  • One patient exhibited delayed kidney function recovery up to 3 months post-discharge.
  • This patient received cephalosporin antibiotics, raising concerns about potential drug-disease interactions impacting renal recovery.

Conclusions:

  • AKI is a significant concern in pediatric DKA admissions.
  • Delayed renal recovery can occur, and the role of nephrotoxic medications in conjunction with DKA warrants further study.
  • Pediatricians must closely monitor kidney function in children with DKA and AKI, considering potential interactions between medications and the disease state.

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
229
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
32
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
42
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
269
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
339